145 related articles for article (PubMed ID: 28089831)
1. Monomethyltransferase SETD8 regulates breast cancer metabolism via stabilizing hypoxia-inducible factor 1α.
Huang R; Yu Y; Zong X; Li X; Ma L; Zheng Q
Cancer Lett; 2017 Apr; 390():1-10. PubMed ID: 28089831
[TBL] [Abstract][Full Text] [Related]
2. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer.
Wu J; Chai H; Xu X; Yu J; Gu Y
Mol Oncol; 2020 Jun; 14(6):1397-1409. PubMed ID: 32291851
[TBL] [Abstract][Full Text] [Related]
3. NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming.
Zhang HS; Du GY; Zhang ZG; Zhou Z; Sun HL; Yu XY; Shi YT; Xiong DN; Li H; Huang YH
Int J Biochem Cell Biol; 2018 Feb; 95():85-92. PubMed ID: 29275212
[TBL] [Abstract][Full Text] [Related]
4. Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase.
Liu Q; Geng H; Xue C; Beer TM; Qian DZ
Biochim Biophys Acta; 2015 May; 1853(5):881-91. PubMed ID: 25637186
[TBL] [Abstract][Full Text] [Related]
5. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.
Liu F; Zhang W; You X; Liu Y; Li Y; Wang Z; Wang Y; Zhang X; Ye L
Oncotarget; 2015 Sep; 6(29):27199-213. PubMed ID: 26309161
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Determinants of Erythropoiesis: Role of the Histone Methyltransferase SetD8 in Promoting Erythroid Cell Maturation and Survival.
DeVilbiss AW; Sanalkumar R; Hall BD; Katsumura KR; de Andrade IF; Bresnick EH
Mol Cell Biol; 2015 Jun; 35(12):2073-87. PubMed ID: 25855754
[TBL] [Abstract][Full Text] [Related]
8. SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression.
Liu M; Shi Y; Hu Q; Qin Y; Ji S; Liu W; Zhuo Q; Fan G; Ye Z; Song C; Yu X; Xu X; Xu W
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1614-1624. PubMed ID: 34599596
[TBL] [Abstract][Full Text] [Related]
9. The histone lysine methyltransferase SETD8 regulates angiogenesis through HES-1 in human umbilical vein endothelial cells.
Choi DK; Kim YK; Park SW; Lee H; Lee S; Kim SA; Kim SJ; Lee J; Kim W; Min SH; Yu JH
Sci Rep; 2020 Jul; 10(1):12089. PubMed ID: 32694555
[TBL] [Abstract][Full Text] [Related]
10. HDAC4 protein regulates HIF1α protein lysine acetylation and cancer cell response to hypoxia.
Geng H; Harvey CT; Pittsenbarger J; Liu Q; Beer TM; Xue C; Qian DZ
J Biol Chem; 2011 Nov; 286(44):38095-38102. PubMed ID: 21917920
[TBL] [Abstract][Full Text] [Related]
11. Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis.
Li Q; Li Y; Liang L; Li J; Luo D; Liu Q; Cai S; Li X
Cell Commun Signal; 2018 Jun; 16(1):26. PubMed ID: 29884183
[TBL] [Abstract][Full Text] [Related]
12. SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC.
Li X; Liu Z; Xia C; Yan K; Fang Z; Fan Y
Cancer Lett; 2022 Feb; 527():150-163. PubMed ID: 34942305
[TBL] [Abstract][Full Text] [Related]
13. Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
Kim SL; Park YR; Lee ST; Kim SW
Int J Oncol; 2017 Dec; 51(6):1809-1820. PubMed ID: 29075793
[TBL] [Abstract][Full Text] [Related]
14. SETD8 promotes glycolysis in colorectal cancer via regulating HIF1α/HK2 axis.
Ke B; Ye K
Tissue Cell; 2023 Jun; 82():102065. PubMed ID: 36921492
[TBL] [Abstract][Full Text] [Related]
15. The histone methyltransferase Setd8 alters the chromatin landscape and regulates the expression of key transcription factors during erythroid differentiation.
Myers JA; Couch T; Murphy Z; Malik J; Getman M; Steiner LA
Epigenetics Chromatin; 2020 Mar; 13(1):16. PubMed ID: 32178723
[TBL] [Abstract][Full Text] [Related]
16. Expression and stability of hypoxia inducible factor 1α in osteosarcoma.
El Naggar A; Clarkson P; Zhang F; Mathers J; Tognon C; Sorensen PH
Pediatr Blood Cancer; 2012 Dec; 59(7):1215-22. PubMed ID: 22544557
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer.
Wada M; Kukita A; Sone K; Hamamoto R; Kaneko S; Komatsu M; Takahashi Y; Inoue F; Kojima M; Honjoh H; Taguchi A; Kashiyama T; Miyamoto Y; Tanikawa M; Tsuruga T; Mori-Uchino M; Wada-Hiraike O; Osuga Y; Fujii T
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339442
[TBL] [Abstract][Full Text] [Related]
18. USP29 Deubiquitinates SETD8 and Regulates DNA Damage-Induced H4K20 Monomethylation and 53BP1 Focus Formation.
Hernández-Reyes Y; Paz-Cabrera MC; Freire R; Smits VAJ
Cells; 2022 Aug; 11(16):. PubMed ID: 36010569
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.
Ha JH; Ward JD; Radhakrishnan R; Jayaraman M; Song YS; Dhanasekaran DN
Oncotarget; 2016 Jun; 7(25):37664-37679. PubMed ID: 27166196
[TBL] [Abstract][Full Text] [Related]
20. High Glucose Induces Endothelial COX2 and iNOS Expression via Inhibition of Monomethyltransferase SETD8 Expression.
Qi J; Wu Q; Cheng Q; Chen X; Zhu M; Miao C
J Diabetes Res; 2020; 2020():2308520. PubMed ID: 32185234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
